Mark Sullivan
Chief Legal Officer at Definium Therapeutics, Inc. (DFTX) since April 2023
Mark Sullivan has filed 30 insider reports with the SEC since February 2021, as chief Legal Officer at Definium Therapeutics, Inc. (DFTX), officer at Mind Medicine (MindMed) Inc. (MNMD) and officer at Sesen Bio, Inc. (CARM). In the last 12 months Mark Sullivan sold $1.45M of stock on the open market. In the latest filing, on September 30, 2026, Mark Sullivan sold 14,051 shares of Definium Therapeutics, Inc. (DFTX) for $514K at an average of $36.57.
- Filings
- 30
- Companies
- 3
- Bought on market
- None
- Sold on market
- $1.89M
Companies where Mark Sullivan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Legal Officersince April 2023 | 494,228 | $1.87M | $29.38 | Sep 30, 2026 | |||
| Officer | Dec 29, 2025 | ||||||
| Officer | 299,694 | $23.4K | Feb 24, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 25, 2026-$514KDFTXChief Legal Officer Sullivan Mark sold $513,845 worth of shares (14,051 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 494,228 units to satisfy withholding taxForm 4Open-market sale10b5-1 plan
- Sep 14, 2026DFTXChief Legal Officer Sullivan Mark was granted 125,000 shares, increasing direct ownership by 33% to 508,279 unitsForm 4Grant or award
- Aug 12, 2026DFTXChief Legal Officer Sullivan Mark was granted 62,500 shares, increasing direct ownership by 19% to 383,071 unitsForm 4Grant or award
- Jun 25, 2026-$586KDFTXChief Legal Officer Sullivan Mark sold $585,750 worth of shares (13,008 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 320,571 units (withholding tax)Form 4Open-market sale10b5-1 plan
- Jun 25, 2026~$548KDFTXMark Sullivan plans to sell 13,008 shares (~$548K)Form 144Planned sale
- Jun 22, 2026DFTXChief Legal Officer Sullivan Mark was granted 62,500 shares, increasing direct ownership by 23% to 333,579 unitsForm 4Grant or award
- Mar 25, 2026-$198KDFTXSEC Form 4 filed by Sullivan MarkForm 4Open-market sale10b5-1 plan
- Mar 25, 2026~$198KDFTXMark Sullivan plans to sell 10,702 shares (~$198K)Form 144Planned sale
- Feb 3, 2026DFTXChief Legal Officer Sullivan Mark was granted 125,000 shares, increasing direct ownership by 44% to 407,576 unitsForm 4Grant or award
- Dec 26, 2025-$148KDFTXChief Legal Officer Sullivan Mark sold $148,244 worth of shares (11,276 units at $13.15), decreasing direct ownership by 4% to 282,576 unitsForm 4Open-market sale10b5-1 plan
- Dec 29, 2025~$148KMNMDMark Sullivan plans to sell 11,276 shares (~$148K)Form 144Planned sale10b5-1 plan
- Sep 25, 2025-$110KDFTXChief Legal Officer Sullivan Mark sold $110,186 worth of shares (11,278 units at $9.77), decreasing direct ownership by 4% to 293,852 unitsForm 4Open-market sale10b5-1 plan
- Sep 25, 2025~$110KMNMDMark Sullivan plans to sell 11,278 shares (~$110K)Form 144Planned sale
- Jun 25, 2025-$78.1KDFTXChief Legal Officer Sullivan Mark sold $78,139 worth of shares (11,491 units at $6.80), decreasing direct ownership by 4% to 305,130 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2025~$78.2KMNMDMark Sullivan plans to sell 11,491 shares (~$78.2K)Form 144Planned sale
- Mar 25, 2025-$44.3KDFTXChief Legal Officer Sullivan Mark sold $44,322 worth of shares (6,576 units at $6.74), decreasing direct ownership by 2% to 316,621 unitsForm 4Open-market sale10b5-1 plan
- Mar 25, 2025~$44.3KMNMDMark Sullivan plans to sell 6,576 shares (~$44.3K)Form 144Planned sale
- Mar 12, 2025DFTXChief Legal Officer Sullivan Mark was granted 150,000 shares, increasing direct ownership by 87% to 323,197 unitsForm 4Grant or award
- Dec 26, 2024-$33.6KDFTXChief Legal Officer Sullivan Mark sold $33,576 worth of shares (4,519 units at $7.43), decreasing direct ownership by 3% to 173,197 unitsForm 4Open-market sale10b5-1 plan
- Dec 26, 2024~$33.6KMNMDMark Sullivan plans to sell 4,519 shares (~$33.6K)Form 144Planned sale
- Sep 25, 2024~$26.5KMNMDMark Sullivan plans to sell 4,430 shares (~$26.5K)Form 144Planned sale10b5-1 plan
- Sep 25, 2024-$26.5KDFTXChief Legal Officer Sullivan Mark sold $26,491 worth of shares (4,430 units at $5.98), decreasing direct ownership by 2% to 177,716 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2024-$129KDFTXChief Legal Officer Sullivan Mark sold $128,906 worth of shares (17,854 units at $7.22), decreasing direct ownership by 9% to 182,146 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2024~$129KMNMDMark Sullivan plans to sell 17,854 shares (~$129K)Form 144Planned sale10b5-1 plan
- Feb 27, 2024DFTXSEC Form 4 filed by Sullivan MarkForm 4Grant or award
- Apr 13, 2023DFTXSEC Form 4 filed by Sullivan MarkForm 4Grant or award
- Apr 13, 2023DFTXMark Sullivan became an insiderForm 3New insider
- Feb 21, 2023-$23.4KCARMSEC Form 4: Sullivan Mark sold $23,393 worth of shares (39,831 units at $0.59), decreasing direct ownership by 12% to 299,694 units to cover withholding taxForm 4Open-market sale
- Feb 18, 2022CARMSEC Form 4: Sullivan Mark was granted 339,525 sharesForm 4Grant or award
- Feb 19, 2021CARMSEC Form 4 filed by Mark SullivanForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Mark Sullivan.
Compare Mark Sullivan with
- Mark Sullivan vs Daniel Karlin2 shared
- Mark Sullivan vs Robert Barrow1 shared
- Mark Sullivan vs Matthew T. Wiley1 shared
- Mark Sullivan vs Brandi Roberts1 shared
- Mark Sullivan vs Carol A Vallone1 shared
- Mark Sullivan vs Andreas Krebs1 shared
Other insiders at the same companies
- Robert BarrowDFTX
- Matthew T. WileyDFTX
- Brandi RobertsDFTX
- Carol A ValloneDFTX
- Andreas KrebsDFTX
- David W GryskaDFTX
- Roger CrystalDFTX
- Roger AdsettDFTX
- Suzanne Louise BruhnDFTX
- Michael KlichinskyCARM
- Carrie LiaoDFTX
- Steven KellyCARM
- Natalie McAndrewCARM
Questions about Mark Sullivan
- What is Mark Sullivan's role at Definium Therapeutics, Inc.?
- Mark Sullivan reports to the SEC as chief Legal Officer at Definium Therapeutics, Inc. (DFTX), according to the latest filing on September 30, 2026. Mark Sullivan has also filed as officer at Mind Medicine (MindMed) Inc. (MNMD) and officer at Sesen Bio, Inc. (CARM).
- How many shares does Mark Sullivan own?
- After the latest filing that states it, Mark Sullivan directly owned 494,228 shares of Definium Therapeutics, Inc. (DFTX) and 299,694 shares of Sesen Bio, Inc. (CARM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Sullivan bought or sold stock recently?
- The most recent open-market sale was on September 25, 2026: sold 14,051 shares of Definium Therapeutics, Inc. (DFTX) for $514K at an average of $36.57.
- How do I get alerts when Mark Sullivan files?
- Follow Mark Sullivan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Sullivan filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Mark Sullivan (SEC CIK 0001331843). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR